- 5 Risultati
prezzo più basso: € 31,98, prezzo più alto: € 312,90, prezzo medio: € 193,22
1
New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control - Ali M. Emran
Ordina
da ZVAB.com
€ 203,61
Spedizione: € 0,001
OrdinaLink sponsorizzato
Ali M. Emran:

New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control - copertina rigida, flessible

1992, ISBN: 0306440350

[EAN: 9780306440359], Neubuch, [SC: 0.0], [PU: Springer US], CANCER; CHEMISTRY; COMPUTER; IMAGING; NUCLEARMEDICINE; POSITRONEMISSIONTOMOGRAPHY(PET); RADIOLOGY; RESEARCH; ULTRASONOGRAPHY, … Altro …

NEW BOOK. Costi di spedizione:Versandkostenfrei. (EUR 0.00) AHA-BUCH GmbH, Einbeck, Germany [51283250] [Rating: 5 (von 5)]
2
New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control - Ali M. Emran
Ordina
da AbeBooks.de
€ 203,61
Spedizione: € 0,001
OrdinaLink sponsorizzato

Ali M. Emran:

New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control - copertina rigida, flessible

1992, ISBN: 0306440350

[EAN: 9780306440359], Neubuch, [PU: Springer US], CANCER; CHEMISTRY; COMPUTER; IMAGING; NUCLEARMEDICINE; POSITRONEMISSIONTOMOGRAPHY(PET); RADIOLOGY; RESEARCH; ULTRASONOGRAPHY, Druck auf A… Altro …

NEW BOOK. Costi di spedizione:Versandkostenfrei. (EUR 0.00) AHA-BUCH GmbH, Einbeck, Germany [51283250] [Rating: 5 (von 5)]
3
New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control
Ordina
da Springer.com
€ 213,99
Spedizione: € 0,001
OrdinaLink sponsorizzato
New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control - nuovo libro

ISBN: 9780306440359

Marking the 200th National Meeting of the American Chemical Society, The Division of Nuclear Chemistry and Technology hosted a group of about 90 scientists from 15 different countries to … Altro …

Nr. 978-0-306-44035-9. Costi di spedizione:Worldwide free shipping, , DE. (EUR 0.00)
4
New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control
Ordina
da amazon.de
€ 31,98
Spedizione: € 3,001
OrdinaLink sponsorizzato
New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control - copertina rigida, flessible

1992, ISBN: 9780306440359

Springer, Gebundene Ausgabe, Auflage: 1991, 531 Seiten, Publiziert: 1992-01-31T00:00:01Z, Produktgruppe: Buch, 5.97 kg, Pharmakologie, Medizin, Kategorien, Bücher, Sonografie, Nuklearmedi… Altro …

Gut Costi di spedizione:Auf Lager. Die angegebenen Versandkosten können von den tatsächlichen Kosten abweichen. (EUR 3.00) Phatpocket Bücher
5
Ordina
da AbeBooks.de
€ 312,90
Spedizione: € 8,021
OrdinaLink sponsorizzato
New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control - copertina rigida, flessible

1992, ISBN: 0306440350

[EAN: 9780306440359], Neubuch, [PU: Springer], pp. 536, Books

NEW BOOK. Costi di spedizione: EUR 8.02 Books Puddle, New York, NY, U.S.A. [70780988] [Rating: 4 (von 5)]

1Poiché alcune piattaforme non trasmettono le condizioni di spedizione e queste possono dipendere dal paese di consegna, dal prezzo di acquisto, dal peso e dalle dimensioni dell'articolo, dall'eventuale iscrizione alla piattaforma, dalla consegna diretta da parte della piattaforma o tramite un fornitore terzo (Marketplace), ecc. è possibile che le spese di spedizione indicate da eurolibro non corrispondano a quelle della piattaforma offerente.

Dati bibliografici del miglior libro corrispondente

Dettagli del libro

Informazioni dettagliate del libro - New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control


EAN (ISBN-13): 9780306440359
ISBN (ISBN-10): 0306440350
Copertina rigida
Copertina flessibile
Anno di pubblicazione: 1992
Editore: Emran, Ali M. Springer
536 Pagine
Peso: 1,189 kg
Lingua: eng/Englisch

Libro nella banca dati dal 2007-11-01T22:08:51+01:00 (Zurich)
Pagina di dettaglio ultima modifica in 2024-01-31T20:39:43+01:00 (Zurich)
ISBN/EAN: 0306440350

ISBN - Stili di scrittura alternativi:
0-306-44035-0, 978-0-306-44035-9
Stili di scrittura alternativi e concetti di ricerca simili:
Autore del libro : ali, roy thomas, thomas anderson, roy james, international group control, fowler james, robert peterson, robert brien, james houston, joseph peterson, harold james
Titolo del libro: new trends radiopharmaceutical synthesis quality assurance regulatory control, out control


Dati dell'editore

Autore: Ali M. Emran
Titolo: New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control
Editore: Springer; Springer US
520 Pagine
Anno di pubblicazione: 1992-01-31
New York; NY; US
Lingua: Inglese
213,99 € (DE)
219,99 € (AT)
236,00 CHF (CH)
Available
XI, 520 p.

BB; Hardcover, Softcover / Medizin/Pharmazie; Pharmakologie; Verstehen; cancer; chemistry; computer; imaging; nuclear medicine; positron emission tomography (PET); radiology; research; Ultrasonography; Pharmacology; Nuclear Medicine; Ultrasonics; Organic Chemistry; Nuklearmedizin; Akustik und Tontechnik; Organische Chemie; EA; BC

1.1 Introductory Remarks.- 1.2 Overview.- 1.3 A Muscarinic Receptor Ligand: Review of the Chemistry and Applications.- 2.1 Aspects on the Synthesis and Design of 11C-Tracers for PET.- 2.2 Special Problems Associated with the Synthesis of High Specific Activity Carbon-11 Labeled Radiotracers.- 2.3 PET Radiopharmaceuticals via Reductive Carboxylation.- 2.4 [13N] Labeled Tracers, Synthesis and Applications.- 2.5 Cu1+ Assisted Nucleophilic Exchange Radiohalogenation: Application and Mechanistic Approach.- 2.6 Potential Breast Tumor Imaging Agents: Fluorotamoxifen and Derivatives.- 2.7 Fluorinated Azabicycloesters as Muscarinic Receptor Ligands for Application with PET.- 2.8 Flourine-18 Ligands for the In Vivo Study of ?-Adrenergic Receptors in the Heart and Lung.- 2.9 Design and Radiofluorination of Benzamide Dopamine D2 Receptor Ligands.- 3.1 A Synthetic Porphyrin with High Affinity for Lung Cancer Cells and Inflamed Lymphatic Tissue.- 3.2 Galium and Copper Radiopharmaceutical Chemistry.- 3.3 Radiometallating Antibodies and Autoantigenic Peptides.- 3.4 Biomedical Use of Arsenic Radioisotopes.- 3.5 Improved Extraction Efficiency of Gallium-67 After Irradiation of Zinc-68 with Protons.- 3.6 Chemistry and Concept for An Automated 72Se/72As Generator.- 3.7 Radiochemistry of Monoclonal Antibody Labeling.- 3.8 The Study on the Formulation of A Tc(V)-99m-DMS Lyophilized Instant Kit for Tumor Scintigraphy.- 3.9 A National Biomedical Tracer Facility.- 3.10 Tantalum-178-Labeled Radiopharmaceutical Synthesis Via The Intermediate Tantalum Pentachloride — A Potential Myocardial Perfusion Agent.- 3.11 Status of Lead and Bismuth for Radioimmunoimaging and Therapy.- 4.1 Use of Organolithium and Organomagnesium Reagents In Radiopharmaceutical Synthesis.- 4.2 Application of OrganosiliconChemistry to the Synthesis of Gamma and Positron Emitting Radiotracers for Use In Nuclear Imaging Studies.- 4.3 The Synthesis of Halogenated Radiopharmaceuticals using Organomercurials.- 4.4 Synthesis of Radiopharmaceuticals Via Organoboranes.- 4.5 Radiosotope Incorporation via Aryl and Alkenyl Trialkyltin Intermediates.- 5.1 Robots In the Radiopharmaceutical Laboratory: Will They Replace the Chemist?.- 5.2 The Use of Transducers for Automated Radiopharmaceutical Synthesis Procedures.- 5.3 Facilitating the Design and Operation of Computer-Controlled Radiochemistry Synthesizers with an “Electronic Toolbox”.- 5.4 Knowledge-Based Automated Radiopharmaceutical Manufacturing for Positron Emission Tomography.- 5.5 Robotic Thin Layer Chromatography Instrument for Synthetic Chemistry.- 5.6 Automated Radiochemical Processing for Clinical PET.- 5.7 Captive Solvent Methods for Fast, Simple, Carbon-11 Radioalkylation.- 6.1 Identity, Strength, Purity, Quality and Safety: Common Goals for New Drugs.- 6.2 Quality Assurance Considerations Related to “In-House” Radiopharmaceutical Preparations Utilizing Positron Emitting Radionuclides.- 6.3 The Role of High Performance Liquid Chromatography In Radiochemical/Radiopharmaceutical Synthesis and Quality Assurance.- 6.4 Experience from a National Quality Assurance System on Radiopharmaceuticals.- 6.5 Radiopharmaceutical Production for PET: Quality Assurance Practice, Experience and Issues.- 6.6 Post-Column Reactor Determination of Aluminum Concentration in Cyclotron Produced Radiorubidium.- 6.7 Implications of the Food, Drug and Cosmetic Act on the Quality Assurance of Radiopharmaceuticals used in the United States.- 6.8 Quality Assurance in Radiochemical/Radiopharmaceutical Manufacturing.- 7.1 Regulatory Control ofRadiopharmaceutics.- 7.2 Regulatory Control of Radiopharmaceuticals.- 7.3 Development of European Regulations on Radiopharmaceuticals.- 7.4 Regulation of Cyclotron Radiopharmaceutical Production and Distribution: An Agreement State Perspective.- 7.5 New Drug Approval Process for Radiopharmaceuticals.- 7.6 Abbreviated New Drug Applications (ANDAS): Future Trends in Radiopharmaceuticals.

< Per archiviare...